Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 27, 2026
Sacituzumab govitecán para el cáncer de mama metastásico triple negativo
De la Dra. Sara Hurvitz, División de Investigación Clínica
Sacituzumab govitecan for metastatic triple-negative breast cancer
From Dr. Sara Hurvitz, Clinical Research Division
Treatment patterns and cost in advanced stage cervical cancer
From the Ramsey Group, Public Health Sciences Division